FANCL expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.66733293838206E-12 |
Normal-vs-Stage2 |
5.24089999953681E-07 |
Normal-vs-Stage3 |
5.14255305006373E-13 |
Normal-vs-Stage4 |
1.63025148935958E-12 |
Stage1-vs-Stage2 |
2.228200E-01 |
Stage1-vs-Stage3 |
2.825800E-01 |
Stage1-vs-Stage4 |
5.347700E-02 |
Stage2-vs-Stage3 |
5.572000E-01 |
Stage2-vs-Stage4 |
9.628800E-01 |
Stage3-vs-Stage4 |
3.892200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.11022302462516E-16 |
Normal-vs-AfricanAmerican |
3.66329999668125E-08 |
Normal-vs-Asian |
9.14170000032577E-07 |
Caucasian-vs-AfricanAmerican |
2.458200E-01 |
Caucasian-vs-Asian |
1.639590E-01 |
AfricanAmerican-vs-Asian |
5.216200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
2.44249065417534E-15 |
Male-vs-Female |
8.909400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.785700E-04 |
Normal-vs-Age(41-60Yrs) |
1.62592161956354E-12 |
Normal-vs-Age(61-80Yrs) |
<1E-12 |
Normal-vs-Age(81-100Yrs) |
2.44189999999422E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.905600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.999400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.446400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.668400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.595600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.586400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.31079999965422E-07 |
Normal-vs-Grade 2 |
1.11022302462516E-16 |
Normal-vs-Grade 3 |
2.99760216648792E-15 |
Normal-vs-Grade 4 |
2.84659995575254E-09 |
Grade 1-vs-Grade 2 |
5.193800E-01 |
Grade 1-vs-Grade 3 |
3.046400E-01 |
Grade 1-vs-Grade 4 |
1.248980E-01 |
Grade 2-vs-Grade 3 |
4.320200E-01 |
Grade 2-vs-Grade 4 |
1.212010E-01 |
Grade 3-vs-Grade 4 |
3.739600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
<1E-12 |
Normal-vs-ccB subtype |
1.71460001752166E-09 |
ccA subtype-vs-ccB subtype |
1.241690E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.62481139653892E-12 |
Normal-vs-N1 |
3.79470000000381E-05 |
N0-vs-N1 |
7.680800E-01 |
|
|